A qualitative study on user acceptance of a home-based stroke telerehabilitation system.
Yu Chen, Yunan Chen, Kai Zheng and 7 others
PMID 31682789WHAT IT FOUND
Stroke patients who used a home telerehabilitation system combining games, exercises, education, and therapist video sessions valued feedback and connection, and found games enjoyable.
They wanted reliable technical support, flexible schedules, and visible progress.
Key findings
01Patients valued the therapist videoconferencing part of the system, which was delivered alongside games, exercises, and education, because therapists could observe movements, correct exercises, answer questions, and adjust difficulty.
02Patients found the combined home system easier to use because games were engaging, home sessions removed travel, and therapist contact helped them stay accountable.
03Before long-term use, patients wanted reliable technical support, more flexible scheduling, and a way to see their progress over time.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
Only 13 patients were interviewed, and they were all from the telerehabilitation group who completed the trial and agreed to interviews. The study was qualitative and did not measure clinical outcomes, so reported improvements are patient perceptions, not tested effects. The system included games, exercises, education, and therapist videoconferencing together, so the contribution of any single component cannot be separated. The paper does not describe how patients were randomly assigned or how assignment was concealed. Technical support was provided by the research team during the study, so acceptance may differ in ordinary home conditions.
Declared interests
The article lists NIH and U.S. government research support. Dr. Cramer declared consulting relationships with MicroTransponder, Dart Neuroscience, Roche, Regenxbio, and TRCare.
The easy way to misread this
Do not read the patients' reported improvement or intention to keep using the system as evidence that the telerehabilitation system improves recovery. This study asked only about acceptance after a completed trial, and it did not test the system against usual therapy or measure clinical outcomes.